Le Lézard
Classified in: Health, Science and technology
Subject: IMA

GlobalMed Announces Compliance with European Medical Device Regulation (MDR)


SCOTTSDALE, Ariz., Feb. 2, 2022 /PRNewswire/ -- GlobalMed, an international provider of virtual health solutions, is proud to announce that its eNcounter® telehealth software suite, ClinicalAccess® Station Lite and multiple diagnostic examination cameras are now compliant to the European Union's (EU) strictest medical device regulation MDR 2017/745. EU-based Medical Technology Promedt Consulting GmbH issued the MDR 2017/745 certificate, effective December 2021, declaring that the submitted GlobalMed products conform to the outlined regulations and are approved to display the CE mark under this new standard which addresses both devices and software.

MDR is a new set of regulations that governs the production and distribution of medical devices in the European Union, EU and will be mandatory for companies that want to sell these products in that marketplace. Compliance with this latest standard ensures that GlobalMed can continue to support the 27 EU member states with its software and hardware virtual telehealth solutions.

"Compliance with the new European medical device standard is another important milestone in our 20-year history, as we strive to make healthcare easily accessible to all individuals - regardless of where they call home," said Joel E. Barthelemy, GlobalMed founder and CEO. "The demand for telemedicine solutions continues to grow across all markets, regardless of geopolitical boundaries. Compliance with MDR not only expands our ability to offer these solutions where they are most needed, but it also shows our commitment to adhering to a quality management system that ensures the performance of our solutions throughout their lifecycle."

The EU MDR compliance expands GlobalMed's offering into Europe, increasing its list of CE-Marked products to include telehealth stations, mobile solutions, telehealth software, digital stethoscopes, exam cameras, otoscopes, conferencing cameras and a range of other medical devices designed for virtual care.

Learn more about GlobalMed's complete line of high-performance telehealth products, including CE Marked products.

About GlobalMed®

GlobalMed powers the world's most advanced virtual health technology platform and wellness applications that support a patient at any point in the continuum of care. Providers are enabled with integrated software and data-capturing tools to deliver a complete and accurate patient encounter for evidence-based treatment and improved patient outcomes. Providers looking to manage capacity, reduce costs, expand patient care, and deliver responsible medicine, will get all they need from one platform.

Specializing in both federal and commercial spaces, GlobalMed technology has enabled approximately 50 million consults in nearly 100 countries. Its highly secure virtual health platform has earned the U.S. Defense Health Agency's Authority to Operate on the DoD network and is used worldwide from the VA and White House Medical Unit to rural American hospitals, correctional facilities, oil rigs, and even villages in Africa. Founded in 2002 by a Marine Corps Reserve Veteran still serving as CEO.

Media Contact:
Kate Lunt
[email protected]
480-922-0014

SOURCE GlobalMed


These press releases may also interest you

at 16:20
Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 330,000 shares of common stock. Awards were made to six new employees of the Company. The...

at 16:19
The Autorité des marchés financiers ("AMF") cautions Québec consumers about the website dr-hypotheque.ca.  According to information...

at 16:15
Block, Inc. will release financial results for the second quarter of 2024 on Thursday, August 1, 2024, after market close. Block will also host a conference call and earnings webcast at 2:00 p.m. Pacific Time/5:00 p.m. Eastern Time on the same day...

at 16:15
Snap Inc. will hold its quarterly conference call to discuss second quarter 2024 financial results on Thursday, August 1, 2024 at 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time). A live webcast and replay of the conference call will be accessible...

at 16:10
bluebird bio, Inc. today announced that the Compensation Committee of the Company's Board of Directors approved an inducement grant of stock options to purchase a total of 300,000 shares of common stock to its chief financial officer, James...

at 16:10
AppLovin Corporation, ("AppLovin" or the "Company") the leading marketing platform, today announced it will report financial results for the second quarter on Wednesday, August 7, 2024 after the U.S. stock market closes. An accompanying webinar...



News published on and distributed by: